vEDS is caused by mutations in collagen, type III, alpha-1 (COL3A1) and its prevalence is estimated between 1:20,0000–50,000 (Omar et al., 2021). This evidence concerns the gene COL3A1 and Ehlers-Danlos syndrome, vascular type.